Intra-Cellular Therapies, Inc.
ITCI
Clasificación en acciones
#1674
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on... Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on creating innovative treatments for conditions affecting the brain and nervous system. The company achieves this by targeting the intricate cellular communication pathways within the central nervous system, primarily operating in the United States. Its commercialized product is CAPLYTA, an approved therapy for schizophrenia in adult patients. Furthermore, the company maintains a robust development pipeline, including lumateperone, which is undergoing late-stage (Phase III) clinical trials for bipolar depression and is also being investigated for autism spectrum disorder and various sleep disturbances associated with neuropsychiatric and neurological illnesses. Other key drug candidates in its pipeline include Lenrispodun (ITI-214), aimed at treating Parkinson's disease and heart failure; ITI-1284-ODT-SL, designed to address neuropsychiatric disorders and behavioral challenges in dementia; and ITI-333, intended for substance use disorders, pain management, and co-occurring psychiatric conditions like depression and anxiety. Established in 2002, Intra-Cellular Therapies, Inc. has its headquarters situated in New York, New York.
Precio por acción
$131.87
Última sincronización: 2025-04-02
Capitalización bursátil
$12.68B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Intra-Cellular Therapies, Inc. (ITCI)
Categoría
Healthcare
Historial del precio de la acción de Intra-Cellular Therapies, Inc. (ITCI)
Precio más alto de cierre: $131.87 el 2025-04-01
Precio más bajo de cierre: $18.58 el 2014-01-01
Precio más bajo de cierre: $18.58 el 2014-01-01
Historial del precio de la acción de Intra-Cellular Therapies, Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2025 | 55.77% |
| 2024 | 28.97% |
| 2023 | 25.44% |
| 2022 | 22.29% |
| 2021 | 54.57% |
| 2020 | 49.37% |
| 2019 | 44.08% |
| 2018 | -15.24% |
| 2017 | -2.14% |
| 2016 | -71.45% |
| 2015 | 222.13% |
| 2014 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $163.01 | 21.90% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $221.29 | 29.22% |
CH
|
|
| $18.45 | -3.94% |
IN
|
